Xenerex And Peregrine Announce Research Collaboration

xenerex-biosciences, a subsidiary of AVANIR Pharmaceuticals, and Peregrine Pharmaceuticals, Inc. have announced that they have entered into an antibody research collaboration agreement, designed to discover, develop and potentially commercialise fully human monoclonal antibody therapies for the treatment of solid tumour cancers. “Our opportunity to work with Peregrine is yet another step forward in validating the unique technology that Xenerex offers to the biopharmaceutical marketplace,” said J. David Hansen, president and chief operating officer of Xenerex Biosciences.

“In partnering with Peregrine, we are expanding the number and types of proteins to which we can apply our antibody generation capabilities. Additionally, we are implementing our strategy of continuing to build our client base with partners also focused on novel treatments and technologies. We look forward to working with Xenerex for the generation of antibodies against several targets we have identified as being promising for our therapeutic antibody programs,” said Steven King, Peregrine’s Vice President of Technology and Product Development.

“Based on the strength of data from pre-clinical animal studies using murine antibodies against several different targets, we felt it was time to begin development of fully human antibodies that could potentially serve as candidates for clinical studies. We believe that Xenerex has the ability to efficiently generate these human antibodies. Based on data from our animal models, we feel that these antibodies have the potential to be used as unconjugated antibodies for the treatment of a variety of different solid tumours.”

Peregrine Pharmaceuticals is a biopharmaceutical company focused on the development, commercialization and licensing of unique technologies for the treatment of cancer.

Best Steroids Online

dragon-pharmaceutical
Dragon Pharma is producing a wide range of steroids EQ 300.

Purchase Dragon Pharmaceutical

Cut Mix 150 - Discount Price

Administration: Injection
Main Component: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Branded by: Dragon Pharma Labs
Package: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $36.00

Cypionat 250 - Cheap Price

Administration: Injection
Basic Substance: Testosterone Cypionate
Manufacturer: Dragon Pharmaceutical
Amount: 20 x 10 mL vial (250 mg/mL)
Price: 20 x $30.00

Primobolan 100 - Cheap Price

Administration: Injection
Principal Substance: Methenolone Enanthate
Produced by: Dragon Pharma LLC
Pack: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $65.00

EQ 300 - Cheap Price

Administration: Injection
Primary Component: Boldenone Undecylenate
Produced by: Dragon Pharmaceutical
Amount: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $35.00

Dianabol

Natural Anabolic Steroidal Agent
Base Substance: Methandrostenolone
Made by: Dragon Pharmaceuticals
Unit: 1 X 100 pills (20 mg/tablet)

Cypionat 250

Injectable Anabolic Steroid
Main Chemical Name: Testosterone Cypionate
Manufacturer: Dragon Pharma
Pack: 1 X 10 ml (250 mg/ml)

Cut Long 300

Injectable Anabolic Steroid
Basic Substance: Drostanolone Enanthate, Testosterone Enanthate, Trenbolone Enanthate
Produced by: Dragon Pharmaceutical
Amount: 1 X 10 ml (300 mg/ml)

EQ 200 / Test E 200

Injectable Steroid for Muscle Growth
Mix of: Boldenone Undecylenate, Testosterone Enanthate
Branded by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (400 mg/mL)

Winstrol 50

Injectable Steroid for Muscle Growth
Active Ingredient: Stanozolol
Produced by: Dragon Pharma
10 mL Sterile Multi-dose Vial (50 mg/mL)

NPP 150

Injectable Steroid for Muscle Growth
Prime Component: Nandrolone Phenylpropionate
Branded by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (150 mg/mL)

Tritren 150

Injectable Steroid for Muscle Growth
Mix of: Trenbolone Acetate,
Trenbolone Enanthate, Trenbolone Hexahydrobenzylcarbonate
Made by: Dragon Pharma
10 mL Sterile Multi-dose Vial (150 mg/mL)

Enantat 250

Primary Chemical Name: Testosterone Enanthate
Manufacturer: Dragon Pharma
Package: 10 x 10 mL vial (250 mg/mL)